"CenExel ACT, formerly Anaheim Clinical Trials (ACT), is a medical research center administrating Phase 1 – 4 clinical trials. For over two decades, CenExel ACT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare. People volunteer to participate in medical research studies for a variety of reasons. Some hope to find a new treatment or cure for their disease. Others are looking for access to new drugs or free medical care. Many want the satisfaction of knowing that they may be helping someone with a chronic condition. We are dedicated to providing cutting edge therapy that can assist in managing patients’ chronic medical conditions today and for a lifetime."

During the past decade, Advanced Clinical Research Institute conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 55 clinical trials were completed, i.e. on average, 87.3% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 36 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Clinical Research Institute" #1 sponsor was "Pfizer" with 11 trials, followed by "Shire" with 11 trials sponsored, "Gilead Sciences" with 8 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Janssen Research & Development, LLC" with 6 trials sponsored. Other sponsors include 112 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Clinical Research Institute" #1 collaborator was "Premier Research Group plc" with 4 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research Institute" are "Crohn's Disease" (15 trials), "Schizophrenia" (11 trials), "Ulcerative Colitis" (8 trials), "Hepatitis C, Chronic" (7 trials) and "Osteoarthritis" (7 trials). Many other conditions were trialed in "Advanced Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Advanced Clinical Research Institute" are "Drug" (146 trials), "Biological" (12 trials), "Other" (11 trials), "Behavioral" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "AC2993" (4 trials), "Ontamalimab" (4 trials), "Ribavirin" (3 trials) and "Seltorexant" (3 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Clinical Research Institute" are 152 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Advanced Clinical Research Institute". undefined are not yet recruiting, 18 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 116 completed trials in Advanced Clinical Research Institute, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Clinical Research Institute, 14 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".